ISSN 1941-5923



American Journal of Case Reports have been selected for the ESCI - Emerging Sources Citation Index (Thomson Reuters, Web of Science, ISI), launching in November of 2015 as a new edition of the Web of Science.

Clinical... read more

Published: 2017-02-27

Chronic Myeloid Leukemia Associated Hypercalcemia: A Case Report and Literature Review

David Toro-Tobón, Sarimar Agosto, Sara Ahmadi, Maureen Koops, Jan M. Bruder

(Department of Medicine, CES University, Medellin, Colombia)

Am J Case Rep 2017; 18:203-207

DOI: 10.12659/AJCR.902467

BACKGROUND: Hypercalcemia associated with chronic myeloid leukemia (CML) is an ominous sign. Although rare, several cases have been reported and multiple pathophysiologic mechanisms have been independently proposed. We present a patient case and a literature review of the clinical presentation and mechanisms of CML-associated hypercalcemia.
CASE REPORT: A 58-year-old male with a past medical history of CML diagnosed six years earlier, presented to the emergency department with one week of acute confusion, disorientation, polyuria, and polydipsia. On physical examination, we observed tachycardia, altered mental status, and dehydration. Blood analysis revealed leukocytosis, thrombocytosis, and marked hypercalcemia (18.6 mg/dL). His chest CT scan showed diffuse lytic lesions and bone destruction concerning for diffuse bone marrow involvement. The patient was diagnosed with hypercalcemia in the context of a CML blast phase. Treatment with hydration, calcitonin, and zoledronic acid lead to control of his symptoms and normalization of his serum calcium levels. After discharged, the patient was maintained on palliative treatment and zoledronic acid management without new episodes of hypercalcemia. However, eight months later, the patient died.
CONCLUSIONS: Evidence from the literature demonstrates a highly variable clinical presentation of CML-associated hypercalcemia, commonly occurring during an accelerated or a blast phase, and associated with poor survival. Multiple mechanisms could be involved and are not exclusive of each other. Better understanding of the pathophysiologic mechanisms involved in CML-associated hypercalcemia could lead to improvement in clinical and laboratory evaluation of these patients and be the foundation for the development of better management strategies and possibly target-directed therapy to positively improve prognosis.

Keywords: case reports, Hypercalcemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Related Articles (0)

Coming Soon...

Published: 2017-02-24

Arterial Pseudoaneurysm Associated with Pancreas and Kidney Transplantation: A Case Report

Rubens Macedo Arantes, Carlos Andrés Rodriguez Pantanali, Vinicius Rocha Santos, Luiz Augusto Carneiro D’Albuquerque

Am J Case Rep 2017; 18:198-202

DOI: 10.12659/AJCR.900790

Published: 2017-02-23

Progressive Ischemic Stroke due to Thyroid Storm-Associated Cerebral Venous Thrombosis

Natsumi Tanabe, Eiji Hiraoka, Masataka Hoshino, Gautam A. Deshpande, Kana Sawada, Yasuhiro Norisue, Jumpei Tsukuda, Toshihiko Suzuki

Am J Case Rep 2017; 18:194-197

DOI: 10.12659/AJCR.902297